AR089244A1 - SISTEMA DE ADMINISTRACION DE ARNip IN VIVO BASADO EN PEPTIDOS - Google Patents

SISTEMA DE ADMINISTRACION DE ARNip IN VIVO BASADO EN PEPTIDOS

Info

Publication number
AR089244A1
AR089244A1 ARP120104720A AR089244A1 AR 089244 A1 AR089244 A1 AR 089244A1 AR P120104720 A ARP120104720 A AR P120104720A AR 089244 A1 AR089244 A1 AR 089244A1
Authority
AR
Argentina
Prior art keywords
peptides
administration
directed
arnip
administration system
Prior art date
Application number
Other languages
English (en)
Spanish (es)
Inventor
B Rozema David
L Lewis David
V Blokhin Andrei
C Carlson Jeffrey
A Kitas Eric
Jahn-Hofmann Kerstin
Martin Mueller Hans
Roehl Ingo
H Wakefield Darren
A Wolff Jon
D Benson Jonathan
Hadwiger Philipp
Hoffmann Torsten
Mohr Peter
Ott Guenther
Original Assignee
Arrowhead Madison Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/326,433 external-priority patent/US8501930B2/en
Application filed by Arrowhead Madison Inc filed Critical Arrowhead Madison Inc
Publication of AR089244A1 publication Critical patent/AR089244A1/es

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ARP120104720 2011-12-15 2012-12-14 SISTEMA DE ADMINISTRACION DE ARNip IN VIVO BASADO EN PEPTIDOS AR089244A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/326,433 US8501930B2 (en) 2010-12-17 2011-12-15 Peptide-based in vivo siRNA delivery system

Publications (1)

Publication Number Publication Date
AR089244A1 true AR089244A1 (es) 2014-08-06

Family

ID=49224588

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120104720 AR089244A1 (es) 2011-12-15 2012-12-14 SISTEMA DE ADMINISTRACION DE ARNip IN VIVO BASADO EN PEPTIDOS

Country Status (3)

Country Link
AR (1) AR089244A1 (zh)
SA (1) SA112340077B1 (zh)
TW (1) TWI565476B (zh)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2427472B1 (en) * 2009-05-05 2016-06-22 Miragen Therapeutics Lipophilic polynucleotide conjugates

Also Published As

Publication number Publication date
TWI565476B (zh) 2017-01-11
SA112340077B1 (ar) 2015-11-10
TW201325622A (zh) 2013-07-01

Similar Documents

Publication Publication Date Title
CL2016001190A1 (es) Cultivo de células de mamífero.
CY1120690T1 (el) Κρυσταλλικη μορφη βενζυλοβενζολικου αναστολεα τουsglt2
BR112012021256A2 (pt) composições para liberação alvejada de sirna.
PH12015501422B1 (en) Hydrophilic self-immolative linkers and conjugates thereof
MX2014005710A (es) Un metodo de cribado de farmaco y usos del mismo.
AR081868A1 (es) Vectores y secuencias de sulfamidasa humana para el tratamiento de mucopolisacaridosis
BR112014013175A2 (pt) composições de liberação prolongada baseadas em lipídios anfipáticos
MY156938A (en) Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
BR112013017382A2 (pt) métodos para preparação de glicoesfingolipídios e usos destes
PE20141160A1 (es) Metodos para preparar analogos nucleotidicos antivirales
UY33776A (es) Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso
ECSP13012788A (es) Derivados de biciclo[3,2,1]octilamida y sus usos
NI201200017A (es) Formulación farmacéutica
BR112013000676A2 (pt) veiculo ermosivel, uso de um fosfolipidio, sisema de distribuição de medicamento, sistema de produção de imagem, sistema, combinado para distrição de medicamento com imagem e método para distribuição orientada por rm de um medicamento a um individuo
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
PE20151519A1 (es) Composicion de liposoma
GT201400003A (es) Una nueva composición terapéutica que contiene apomorfina como principio activo
CR20160147A (es) Formulaciones de anticuerpos
CR20130530A (es) Derivados glucósidos y sus usos para el tratamiento de la diabetes
IN2014DN00277A (zh)
BR112013022556A2 (pt) composição farmacêutica aquosa semissólida contendo tapentadol
GT201300084A (es) Conjugado de naloxol-peg cristalino
CR20120146A (es) Derivados de espirolactama y usos de los mismos
BR112012028919A2 (pt) sal da rupatadina como um agente anti-histamínico
ES2403549R1 (es) Co-cristales de agomelatina con formadores de co-cristales

Legal Events

Date Code Title Description
FB Suspension of granting procedure